Follow-Up of the Prevision® Hip Stem (PRESPECT)

November 17, 2022 updated by: Aesculap AG

Retrospective Follow-Up of the Prevision® Hip Stem in a Consecutive Case Series

The main objective of this study is to represent the treatment reality at the study site and to draw conclusions from cases of failure or suboptimal outcome. Potential risk factors for revision surgery, suboptimal outcome or radiologic sign of loosening, bone non-union or stem subsidence will be evaluated. Next to the functional outcome, stem subsidence will be used as an important indicator for a stable fixation of the revision stem.

Study Overview

Study Type

Observational

Enrollment (Actual)

46

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bad Mergentheim, Germany, 97980
        • Caritas-Krankenhaus Bad Mergentheim, Klinik für Orthopädie und Unfallchirurgie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients were implanted 2-7 year before the start of the retrospective study activities.

Description

Inclusion Criteria:

  • All patients implanted with a Prevision® hip stem at the study site between 2014 and 2019
  • Written informed patient consent

Exclusion Criteria:

- Patients < 18 years at surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip stem survival measured by Kaplan-Meier
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
The primary endpoint of the study is hip stem survival, which is a common indicator for implant performance, which can also be used for comparison with implant registry data.
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Outcome: Oxford Hip Score
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
The Oxford Hip Score is a 12-item questionnaire that assesses hip function and pain. The score ranges between 12 and 60, with a lower score indicating less disability
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Patient satisfaction with their endoprosthetic revision treatment
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation

The Patients are asked to grade their level of satisfaction with the outcome of the surgery at time of follow-up, with the grades: "very dissatisfied", "dissatisfied", "satisfied", "very satisfied".

The grades may be summarized as "satisfied" vs. "dissatisfied".

One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): Bone healing
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation

Union of the osteotomy

o Healing of the fracture and of the greater trochanter, if applicable

One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): osseointegration
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Distal and proximal radiographic bone ingrowth and Qualitative proximal remodeling
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): radiographic loosening
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Signs of radiographic loosening in the distal fixation zone
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): stem subsidence
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Stem subsidence from ap x-rays using landmarks of the femur (typically lesser trochanter) and of the prosthesis
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Leg length difference
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Discrepancy of leg length is often considered to be a problem after total hip replacement and can adversely affect an otherwise excellent outcome and may be associated with patient dissatisfaction.
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Descriptive Analysis of (Serious) adverse events
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
(Serious) adverse events that are potentially related to the Total hip arthroplasty (THA) procedure or the THA implants will be recorded. These are events as reported by the patient, observed in the follow-up examinations or taken from the patient record
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Descriptive Analysis of Patient characteristics
Time Frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Age, weight, gender, date of surgery, indication for revision, comorbidities, intraoperative details
One scheduled Follow-Up visit per patient, 2-7 years after initial implantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2021

Primary Completion (Actual)

June 13, 2022

Study Completion (Actual)

June 13, 2022

Study Registration Dates

First Submitted

April 1, 2021

First Submitted That Met QC Criteria

April 5, 2021

First Posted (Actual)

April 6, 2021

Study Record Updates

Last Update Posted (Actual)

November 18, 2022

Last Update Submitted That Met QC Criteria

November 17, 2022

Last Verified

November 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periprosthetic Fracture Around Prosthetic Joint Implant

3
Subscribe